Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Cancer

Date Submitted: Dec 18, 2024
Date Accepted: May 12, 2025

The final, peer-reviewed published version of this preprint can be found here:

Design and Validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Women Experiencing Socioeconomic Disadvantage: User-Centered Approach Study

Le Bonniec A, Sauvaget C, Lucas E, Nassiri A, Selmouni F

Design and Validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Women Experiencing Socioeconomic Disadvantage: User-Centered Approach Study

JMIR Cancer 2025;11:e70251

DOI: 10.2196/70251

PMID: 40705442

PMCID: 12332448

Design and validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Disadvantaged Women in France: A User-Centered Approach

  • Alice Le Bonniec; 
  • Catherine Sauvaget; 
  • Eric Lucas; 
  • Abdelhak Nassiri; 
  • Farida Selmouni

ABSTRACT

Background:

Cervical cancer screening participation remains suboptimal among vulnerable populations in France. This study aimed to develop and evaluate AppDate-You, a chatbot-based decision aid to support informed decision-making about cervical cancer screening, particularly HPV self-sampling, among women from disadvantaged areas in the Occitanie region.

Objective:

This study aimed to assess the effectiveness of a chatbot-based decision aid to improve women’s participation in the HPV self-sampling (HPVss) detection-based cervical cancer screening (CCS) care pathway.

Methods:

The chatbot was developed following Coulter's framework based on the International Patient Decision Aid Standards. The process included qualitative research with women and healthcare professionals, followed by 'alpha' testing with both groups and 'beta' testing with women only. AppDate-You was accessible through WhatsApp and Facebook Messenger, offering text-based and voice-based interactions and multimedia content.

Results:

The exploratory phase identified key barriers to screening and preferences for digital tools. Prototype testing revealed high user satisfaction with the chatbot's performance, educational value, and content quality. Contrary to healthcare professionals' expectations, women from diverse backgrounds, including older and socioeconomically disadvantaged individuals, demonstrated willingness and ability to engage with the tool. Users found AppDate-You innovative, user-friendly, and informative, even those with limited digital literacy. In the 'beta' testing, 12 out of 15 participants expressed interest in using HPV self-sampling. Some chatbot’s limitations were identified, such as occasional repetitive responses and the need for clearer explanations of some medical terminology.

Conclusions:

This study demonstrates the potential of AI chatbots in improving health education and promoting cervical screening behaviors among underserved populations. The user-centered development process resulted in a tool that effectively meets the needs of the target population. Clinical Trial: ClinicalTrials.gov NCT05286034; https://clinicaltrials.gov/ct2/show/NCT05286034?term=NCT05286034


 Citation

Please cite as:

Le Bonniec A, Sauvaget C, Lucas E, Nassiri A, Selmouni F

Design and Validation of a Chatbot-Based Cervical Cancer Screening Decision Aid for Women Experiencing Socioeconomic Disadvantage: User-Centered Approach Study

JMIR Cancer 2025;11:e70251

DOI: 10.2196/70251

PMID: 40705442

PMCID: 12332448

Per the author's request the PDF is not available.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.